Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Research

Executive Summary: Meropenem trihydrate is a broad-spectrum carbapenem β-lactam antibiotic active against gram-negative, gram-positive, and anaerobic bacteria at low minimum inhibitory concentrations (MIC90) under physiological pH conditions (APExBIO). Its primary mechanism is the inhibition of bacterial cell wall synthesis via binding to penicillin-binding proteins. Metabolomics studies have demonstrated its relevance in phenotyping carbapenem resistance mechanisms (Dixon et al., 2025). Meropenem trihydrate exhibits high solubility in water (≥20.7 mg/mL) and DMSO (≥49.2 mg/mL), but is insoluble in ethanol. The compound is supplied as a solid and is intended solely for scientific research applications, not for diagnostic or clinical use.

Biological Rationale

Carbapenems such as meropenem trihydrate are critical for research into multidrug-resistant bacterial infections. Meropenem is structurally stable against most β-lactamases, conferring activity against extended-spectrum β-lactamase (ESBL) producing organisms (Dixon et al., 2025). Its spectrum encompasses clinically relevant pathogens including Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and Streptococcus spp. The global rise of carbapenemase-producing Enterobacterales highlights the need for reliable compounds in resistance mechanism studies and metabolomics workflows.

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate acts by irreversibly binding to penicillin-binding proteins (PBPs) in bacterial cell walls. This binding inhibits transpeptidase activity, disrupting peptidoglycan cross-linking, and causes cell lysis. The antibiotic is effective at physiological pH (7.5), with significantly lower activity at acidic pH (5.5), which should be considered in experimental design (APExBIO). Unlike many β-lactams, meropenem is less susceptible to hydrolysis by most class A, C, and D β-lactamases. However, carbapenemase-producing strains, especially those expressing KPC, NDM, or OXA-48 enzymes, can confer resistance by hydrolyzing the carbapenem core (Dixon et al., 2025).

Evidence & Benchmarks

• Meropenem trihydrate exhibits MIC90 values <1 μg/mL against E. coli and K. pneumoniae at pH 7.5, outperforming many other β-lactams (APExBIO).
• It maintains activity in preclinical models, reducing infection and tissue damage in acute necrotizing pancreatitis in rats (APExBIO).
• LC-MS/MS metabolomics can differentiate carbapenemase-producing Enterobacterales from non-resistant strains in under 7 hours, facilitating rapid phenotyping (Dixon et al., 2025).
• Metabolic pathway shifts in resistant strains include arginine metabolism, ATP-binding cassette transporters, and purine metabolism (Dixon et al., 2025).
• Meropenem trihydrate’s solubility in water (≥20.7 mg/mL, gentle warming) and DMSO (≥49.2 mg/mL) enables versatile assay integration (APExBIO).

This article extends previous coverage by providing benchmark data and integrating metabolomics findings for resistance phenotyping, as discussed in this prior review (which focused on general mechanisms) and this application overview (which emphasized translational metabolomics). Here, we update best-practice integration for experimental workflows.

Applications, Limits & Misconceptions

Meropenem trihydrate is widely applied in:

• Antibiotic resistance studies, especially involving Enterobacterales and other gram-negative bacteria (Dixon et al., 2025).
• Metabolomics and biomarker discovery workflows, leveraging its compatibility with LC-MS/MS-based platforms.
• Preclinical models of infection, including acute necrotizing pancreatitis (APExBIO).
• Evaluations of β-lactamase stability and penicillin-binding protein inhibition.

However, its use is not appropriate for diagnostic or clinical therapy; it is a reagent for research purposes only (APExBIO).

Common Pitfalls or Misconceptions

• Meropenem trihydrate does not reliably inhibit carbapenemase-producing strains possessing high-level carbapenemase activity (e.g., KPC, NDM, OXA-48)
• Solubility is high in water and DMSO but negligible in ethanol; improper solvent selection may compromise assay validity
• Activity is pH-dependent; efficacy drops if assays are conducted below physiological pH (7.5)
• Compound is for research use only—not suitable for clinical or diagnostic application
• Long-term storage of solutions is not recommended; instability may lead to loss of activity

Workflow Integration & Parameters

For optimal results, meropenem trihydrate should be stored at –20 °C in solid form. Prepare solutions freshly, using water (≥20.7 mg/mL with gentle warming) or DMSO (≥49.2 mg/mL). Avoid ethanol as it is insoluble in this solvent (APExBIO). In resistance phenotyping assays, physiological pH is critical for accurate MIC assessment. Integrate with LC-MS/MS-based metabolomics platforms for rapid discrimination of resistance phenotypes (Dixon et al., 2025). For further workflow guidance, see scenario-driven solutions in this article, which this review extends by benchmarking metabolomics-driven applications.

Conclusion & Outlook

Meropenem trihydrate (SKU B1217, APExBIO) is a robust research-grade carbapenem antibiotic with high value in studies of bacterial infection and resistance. Its broad-spectrum activity, β-lactamase stability, and compatibility with advanced metabolomics workflows support its role as a benchmark in experimental antibacterial research. Ongoing advances in metabolomic phenotyping and resistance biomarker discovery will continue to expand its usage in preclinical and translational research environments.